Laproscopic hepatectomy
Showing 1 - 25 of 334
Primary Liver Cancer, Metastatic Liver Cancer, Benign Liver Tumors Trial
Not yet recruiting
- Primary Liver Cancer
- +3 more
- (no location specified)
Aug 1, 2023
Liver Regeneration, Ursodeoxycholic Acid, Partial Liver Resection Trial in New Delhi (Ursodeoxycholic acid, Standard Medical
Not yet recruiting
- Liver Regeneration
- +2 more
- Ursodeoxycholic acid
- Standard Medical Treatment
-
New Delhi, IndiaInstitute of Liver and Biliary Sciences
Oct 18, 2023
Nasopharyngeal Carcinoma, Liver Metastases Trial in Shanghai (Hepatectomy)
Not yet recruiting
- Nasopharyngeal Carcinoma
- Liver Metastases
- Hepatectomy
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Mar 4, 2023
Predicting Complications of Hepatolithiasis After Hepatectomy
Enrolling by invitation
- Liver Diseases
- Complication
- radiological evaluation
-
Wenzhou, Zhejiang, ChinaGang Chen
Sep 23, 2022
Adjuvant Immune Checkpoint Inhibitors in Postoperative
Recruiting
- Hepatocellular Carcinoma
- Immune Checkpoint Inhibitors Based Adjuvant therapy
-
Nanning, Guangxi, ChinaJian-Hong Zhong
Jan 18, 2023
Hepatic Hemangioma, Liver Cancer, Hepatolithiasis Trial in Chongqing (Sham-Remote Ischemic Conditioning, Remote Ischemic
Recruiting
- Hepatic Hemangioma
- +3 more
- Sham-Remote Ischemic Conditioning
- +2 more
-
Chongqing, ChinaThe Second Affiliated Hospital, Chongqing Medical University
Nov 8, 2023
Hepatocellular Carcinoma Trial in Wuhan (Sintilimab, Transarterial Chemoembolization (TACE))
Not yet recruiting
- Hepatocellular Carcinoma
- Sintilimab
- Transarterial Chemoembolization (TACE)
-
Wuhan, Hubei, ChinaTongji Hospital, Tongji Medical College, Huazhong University of
Oct 17, 2023
Hepatocellular Carcinoma Trial in Wuhan (Sintilimab, Lenvatinib, Transarterial Chemoembolization (TACE))
Not yet recruiting
- Hepatocellular Carcinoma
- Sintilimab
- +2 more
-
Wuhan, Hubei, ChinaTongji Hospital, Tongji Medical College, Huazhong University of
Oct 17, 2023
Relapse After Conversion Hepatectomy for Initially Unresectable
Completed
- Colorectal Cancer
- Liver Metastases
- Repeat Liver Surgery
- Non-Repeat Liver Surgery
- (no location specified)
Jul 16, 2022
Postoperative Outcomes in Chinese HCC Patients Treated With
Recruiting
- Hepatocellular Carcinoma
-
Shanghai, Shanghai, ChinaZhongshan Hospital, Fudan University
Aug 1, 2023
Laparoscopic Hepatectomy, Nerve Block Trial in WuHan (erector spinae plane block)
Not yet recruiting
- Laparoscopic Hepatectomy
- Nerve Block
- erector spinae plane block
-
WuHan, Hubei, ChinaTongji Hospital, Tongji Medical College, Huazhong University of
Nov 13, 2023
Hepatic Ischemia Trial in Nanjing (sodium bicarbonate Ringer's solution)
Recruiting
- Hepatic Ischemia
- sodium bicarbonate Ringer's solution
-
Nanjing, Jiangsu, ChinaShijiang Liu
Apr 25, 2023
Laparoscopic Liver Resection, Vascular Occlusion, Tourniquet Trial in Hefei (BULLDOG ,A Useful Vascular Occlusion Tourniquet In
Not yet recruiting
- Laparoscopic Liver Resection
- +2 more
- BULLDOG ,A Useful Vascular Occlusion Tourniquet In Laparoscopic Liver Resection
- cotton tourniquet
-
Hefei, Anhui, ChinaThe 2nd affiliated hospital of Anhui Medical University
Feb 18, 2020
Vitamin D Deficiency, Hepatocellular Carcinoma, Perioperative Complication Trial (Vitamin D, Placebo)
Not yet recruiting
- Vitamin D Deficiency
- +2 more
- Vitamin D
- Placebo
- (no location specified)
Dec 6, 2022
Prognostic Models for HCC Based on Tumor Micronecrosis
Recruiting
- Hepatocellular Carcinoma
- observing whether HCC patients having tumor micronecrosis
-
Hangzhou, Zhejiang, Chinathe First Affiliated Hospital, School of Medicine, Zhejiang Univ
Apr 27, 2023
Liver Cancer, Sarcopenia Trial in Wenzhou (gait speed; ct scan;grip strength and chair stand test)
Enrolling by invitation
- Liver Cancer
- Sarcopenia
- gait speed; ct scan;grip strength and chair stand test
-
Wenzhou, Zhejiang, ChinaGang Chen
Jun 14, 2022
Interpretable Deep Learning Framework for Post-Hepatectomy Liver
Not yet recruiting
- Post-hepatectomy Liver Failure
- +2 more
- The explanation of deep learning framework (VAE-MLP) , including counterfactual explanations and layerwise relevance propagation
- +2 more
-
Guangzhou, Guangdong, ChinaThe First Affiliated Hospital of Sun Yat-Sen University
Sep 4, 2023
Hepatopathy Trial in Shanghai (Hetrombopag, Placebo)
Recruiting
- Hepatopathy
- Hetrombopag
- Placebo
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Aug 7, 2022
End Stage Liver Disease, Acute Liver Failure, Acute-On-Chronic Liver Failure Trial in Riyadh (Donor hepatectomy)
Enrolling by invitation
- End Stage Liver Disease
- +3 more
- Donor hepatectomy
-
Riyadh, Saudi ArabiaOrgan Transplant Center of Excellence, King Faisal Specialist Ho
Sep 28, 2023
Portosystemic Shunt Trial (Temporary Portocaval Shunt)
Not yet recruiting
- Portosystemic Shunt
- Temporary Portocaval Shunt
- (no location specified)
May 19, 2022
Hepatocellular Carcinoma, Recurrence, Immune Checkpoint Inhibitor Trial in Nanning (Adjuvant tislelizumab plus lenvatinib,
Not yet recruiting
- Hepatocellular Carcinoma
- +2 more
- Adjuvant tislelizumab plus lenvatinib
- Adjuvant tislelizumab
-
Nanning, ChinaJian-Hong Zhong
Jun 11, 2023
Hepatic Carcinoma, Hepatic Metastasis Trial in Pamplona (Octreotide, Placebo)
Recruiting
- Hepatic Carcinoma
- Hepatic Metastasis
- Octreotide
- Placebo
-
Pamplona, SpainClinica Universidad de Navarra
Oct 10, 2023
Liver Transplant Disorder, Hepatic Cancer Trial (assisted liver transplantation combined with two-stage hepatectomy)
Not yet recruiting
- Liver Transplant Disorder
- Hepatic Cancer
- assisted liver transplantation combined with two-stage hepatectomy
- (no location specified)
Mar 6, 2023
Hepatocellular Carcinoma Trial in Nanjing (hypovolemic phlebotomy)
Recruiting
- Hepatocellular Carcinoma
- hypovolemic phlebotomy
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital of Nanjing Medical University
Jun 1, 2023